Sandra Torres

Sandra Torres has a diverse work experience spanning several companies and roles.

Sandra began their career at the University of Rhode Island as a Laboratory Teaching Assistant, where they instructed introductory and general chemistry laboratory classes, prepared materials, assisted students, and graded laboratory reports. Sandra held this position from 2008 to 2012.

In 2012, Sandra joined UCSF as a Graduate Student Assistant for the UCSF Summer Research Training Program. In this role, they advised college students conducting research at UCSF, facilitated weekly meetings discussing scientific articles, and assisted students with drafting scientific abstracts, oral presentations, and poster presentations. Sandra occupied this role until 2015.

Simultaneously, Sandra worked as a Graduate Student at UCSF from 2012 to 2019. During their time as a Graduate Student, they pursued their Ph.D., focusing on the identification of the molecular target of an unfolded protein response sensor ATF6 inhibitor. Sandra uncovered a novel mechanism of small molecule inhibition, conducted a genome-wide CRISPRi screen, generated CRISPRi knock-down cell lines, and purified proteins for in vitro reconstitution of small molecule-induced tethering.

In 2019, Sandra joined Genentech as a Postdoctoral Researcher. In this role, they continued their research on the ATF6 inhibitor until February 2023.

Currently, Sandra is working at Lycia Therapeutics as a Scientist II, beginning in February 2023.

Sandra Torres earned their Doctor of Philosophy (PhD) degree in Biochemistry and Molecular Biology from the University of California, San Francisco. Sandra was enrolled at the university from 2012 to 2019. Prior to that, they obtained a Bachelor of Science (BS) degree in Biochemistry from Brown University. Unfortunately, no further details about their educational background at the University of California, San Francisco are available.